Anyone who has paid the slightest bit of attention to the technology press in recent years knows that the patent system is out of control. Barely a week goes by here at Ars that we don't report on an ...

Pharmaceutical patent owners have been one of the more vocal groups decrying the creation and existence of inter partes reviews and other PTAB post-issuance proceedings. And for good reason. Congress ...

Patents are interesting things. While they do not directly provide information on guaranteed products which will hit the market in the near (or long term) future, what they do is provide insight to ...